(WEN) The Wendy’s - Overview
Sector: Consumer CyclicalIndustry: Restaurants | Exchange NASDAQ (USA) | Currency USD | Market Cap: 1.350m | Total Return -51.8% in 12m
Stock: Burgers, Chicken, Salads, Desserts, Breakfast
Total Rating 38
Risk 57
Buy Signal -1.10
| Risk 5d forecast | |
|---|---|
| Volatility | 31.0% |
| Relative Tail Risk | -6.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.74 |
| Alpha | -57.38 |
| Character TTM | |
|---|---|
| Beta | 0.255 |
| Beta Downside | 0.684 |
| Drawdowns 3y | |
|---|---|
| Max DD | 66.12% |
| CAGR/Max DD | -0.43 |
EPS (Earnings per Share)
Revenue
Description: WEN The Wendy’s March 05, 2026
The Wendys Company (WEN) operates, develops, and franchises quick-service restaurants globally. The companys business model relies on both company-owned and franchised locations, a common strategy in the restaurant industry to expand reach and reduce capital expenditure.
WENs menu offers typical fast-food items like hamburgers, chicken sandwiches, fries, and desserts, alongside breakfast options. The company segments its operations into Wendys U.S., Wendys International, and Global Real Estate & Development, reflecting its dual focus on domestic and international markets and its ownership of real estate assets.
As of December 28, 2025, Wendys had 5,969 restaurants in the U.S. and 1,428 internationally across 38 countries. This extensive network is characteristic of established quick-service restaurant chains. For further insights into WENs operational metrics and financial performance, consider exploring ValueRays detailed reports.
Headlines to watch out for
- Franchise royalty and fee growth boosts revenue
- Commodity price fluctuations impact food costs
- Labor wage increases pressure operating margins
- International expansion drives new market penetration
- Consumer discretionary spending affects sales volume
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 165.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.29 > 1.0 |
| NWC/Revenue: 12.26% < 20% (prev 15.07%; Δ -2.81% < -1%) |
| CFO/TA 0.07 > 3% & CFO 344.5m > Net Income 165.1m |
| Net Debt (3.84b) to EBITDA (426.1m): 9.02 < 3 |
| Current Ratio: 1.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (190.5m) vs 12m ago -7.07% < -2% |
| Gross Margin: 27.17% > 18% (prev 0.35%; Δ 2.68k% > 0.5%) |
| Asset Turnover: 43.58% > 50% (prev 44.62%; Δ -1.04% > 0%) |
| Interest Coverage Ratio: 2.05 > 6 (EBITDA TTM 426.1m / Interest Expense TTM 126.5m) |
Altman Z'' 1.08
| A: 0.05 (Total Current Assets 618.0m - Total Current Liabilities 351.1m) / Total Assets 4.96b |
| B: 0.09 (Retained Earnings 435.1m / Total Assets 4.96b) |
| C: 0.05 (EBIT TTM 259.4m / Avg Total Assets 5.00b) |
| D: 0.09 (Book Value of Equity 418.2m / Total Liabilities 4.84b) |
| Altman-Z'' Score: 1.08 = BB |
Beneish M -2.40
| DSRI: 1.21 (Receivables 117.3m/99.9m, Revenue 2.18b/2.25b) |
| GMI: 1.31 (GM 27.17% / 35.48%) |
| AQI: 1.39 (AQ_t 0.68 / AQ_t-1 0.49) |
| SGI: 0.97 (Revenue 2.18b / 2.25b) |
| TATA: -0.04 (NI 165.1m - CFO 344.5m) / TA 4.96b) |
| Beneish M-Score: -2.40 (Cap -4..+1) = BBB |
What is the price of WEN shares?
As of March 29, 2026, the stock is trading at USD 6.80 with a total of 7,905,781 shares traded.
Over the past week, the price has changed by -4.09%, over one month by -9.57%, over three months by -16.75% and over the past year by -51.84%.
Over the past week, the price has changed by -4.09%, over one month by -9.57%, over three months by -16.75% and over the past year by -51.84%.
Is WEN a buy, sell or hold?
The Wendy’s has received a consensus analysts rating of 3.28.
Therefor, it is recommend to hold WEN.
- StrongBuy: 5
- Buy: 2
- Hold: 19
- Sell: 2
- StrongSell: 1
What are the forecasts/targets for the WEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 8 | 17.4% |
| Analysts Target Price | 8 | 17.4% |
WEN Fundamental Data Overview March 29, 2026
P/E Trailing = 8.3412
P/E Forward = 12.0337
P/S = 0.62
P/B = 11.5141
P/EG = 1.2034
Revenue TTM = 2.18b USD
EBIT TTM = 259.4m USD
EBITDA TTM = 426.1m USD
Long Term Debt = 2.73b USD (from longTermDebt, last quarter)
Short Term Debt = 107.5m USD (from shortTermDebt, last quarter)
Debt = 4.15b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.84b USD (from netDebt column, last quarter)
Enterprise Value = 5.19b USD (1.35b + Debt 4.15b - CCE 300.8m)
Interest Coverage Ratio = 2.05 (Ebit TTM 259.4m / Interest Expense TTM 126.5m)
EV/FCF = 21.41x (Enterprise Value 5.19b / FCF TTM 242.6m)
FCF Yield = 4.67% (FCF TTM 242.6m / Enterprise Value 5.19b)
FCF Margin = 11.15% (FCF TTM 242.6m / Revenue TTM 2.18b)
Net Margin = 7.58% (Net Income TTM 165.1m / Revenue TTM 2.18b)
Gross Margin = 27.17% ((Revenue TTM 2.18b - Cost of Revenue TTM 1.59b) / Revenue TTM)
Gross Margin QoQ = 24.21% (prev 26.48%)
Tobins Q-Ratio = 1.05 (Enterprise Value 5.19b / Total Assets 4.96b)
Interest Expense / Debt = 0.78% (Interest Expense 32.5m / Debt 4.15b)
Taxrate = 20.22% (6.71m / 33.2m)
NOPAT = 206.9m (EBIT 259.4m * (1 - 20.22%))
Current Ratio = 1.76 (Total Current Assets 618.0m / Total Current Liabilities 351.1m)
Debt / Equity = 35.31 (Debt 4.15b / totalStockholderEquity, last quarter 117.4m)
Debt / EBITDA = 9.02 (Net Debt 3.84b / EBITDA 426.1m)
Debt / FCF = 15.84 (Net Debt 3.84b / FCF TTM 242.6m)
Total Stockholder Equity = 117.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.30% (Net Income 165.1m / Total Assets 4.96b)
RoE = 140.6% (Net Income TTM 165.1m / Total Stockholder Equity 117.4m)
RoCE = 9.11% (EBIT 259.4m / Capital Employed (Equity 117.4m + L.T.Debt 2.73b))
RoIC = 7.25% (NOPAT 206.9m / Invested Capital 2.85b)
WACC = 2.16% (E(1.35b)/V(5.49b) * Re(6.88%) + D(4.15b)/V(5.49b) * Rd(0.78%) * (1-Tc(0.20)))
Discount Rate = 6.88% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -100.0 | Cagr: -4.19%
[DCF] Terminal Value 86.85% ; FCFF base≈249.9m ; Y1≈263.6m ; Y5≈311.0m
[DCF] Fair Price = 28.07 (EV 9.19b - Net Debt 3.84b = Equity 5.34b / Shares 190.4m; r=6.0% [WACC]; 5y FCF grow 5.96% → 3.0% )
EPS Correlation: 4.41 | EPS CAGR: -1.60% | SUE: 0.45 | # QB: 0
Revenue Correlation: 51.35 | Revenue CAGR: 2.85% | SUE: 0.87 | # QB: 2
EPS next Quarter (2026-06-30): EPS=0.19 | Chg7d=+0.000 | Chg30d=-0.000 | Revisions Net=-20 | Analysts=25
EPS current Year (2026-12-31): EPS=0.58 | Chg7d=+0.000 | Chg30d=-0.000 | Revisions Net=+1 | Growth EPS=-33.6% | Growth Revenue=+1.3%
EPS next Year (2027-12-31): EPS=0.66 | Chg7d=+0.000 | Chg30d=-0.021 | Revisions Net=-17 | Growth EPS=+13.5% | Growth Revenue=+1.0%
[Analyst] Revisions Ratio: -1.00 (0 Up / 20 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -4.1% (Discount Rate 7.9% - Earnings Yield 12.0%)
[Growth] Growth Spread = +4.6% (Analyst 0.5% - Implied -4.1%)
P/E Forward = 12.0337
P/S = 0.62
P/B = 11.5141
P/EG = 1.2034
Revenue TTM = 2.18b USD
EBIT TTM = 259.4m USD
EBITDA TTM = 426.1m USD
Long Term Debt = 2.73b USD (from longTermDebt, last quarter)
Short Term Debt = 107.5m USD (from shortTermDebt, last quarter)
Debt = 4.15b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.84b USD (from netDebt column, last quarter)
Enterprise Value = 5.19b USD (1.35b + Debt 4.15b - CCE 300.8m)
Interest Coverage Ratio = 2.05 (Ebit TTM 259.4m / Interest Expense TTM 126.5m)
EV/FCF = 21.41x (Enterprise Value 5.19b / FCF TTM 242.6m)
FCF Yield = 4.67% (FCF TTM 242.6m / Enterprise Value 5.19b)
FCF Margin = 11.15% (FCF TTM 242.6m / Revenue TTM 2.18b)
Net Margin = 7.58% (Net Income TTM 165.1m / Revenue TTM 2.18b)
Gross Margin = 27.17% ((Revenue TTM 2.18b - Cost of Revenue TTM 1.59b) / Revenue TTM)
Gross Margin QoQ = 24.21% (prev 26.48%)
Tobins Q-Ratio = 1.05 (Enterprise Value 5.19b / Total Assets 4.96b)
Interest Expense / Debt = 0.78% (Interest Expense 32.5m / Debt 4.15b)
Taxrate = 20.22% (6.71m / 33.2m)
NOPAT = 206.9m (EBIT 259.4m * (1 - 20.22%))
Current Ratio = 1.76 (Total Current Assets 618.0m / Total Current Liabilities 351.1m)
Debt / Equity = 35.31 (Debt 4.15b / totalStockholderEquity, last quarter 117.4m)
Debt / EBITDA = 9.02 (Net Debt 3.84b / EBITDA 426.1m)
Debt / FCF = 15.84 (Net Debt 3.84b / FCF TTM 242.6m)
Total Stockholder Equity = 117.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.30% (Net Income 165.1m / Total Assets 4.96b)
RoE = 140.6% (Net Income TTM 165.1m / Total Stockholder Equity 117.4m)
RoCE = 9.11% (EBIT 259.4m / Capital Employed (Equity 117.4m + L.T.Debt 2.73b))
RoIC = 7.25% (NOPAT 206.9m / Invested Capital 2.85b)
WACC = 2.16% (E(1.35b)/V(5.49b) * Re(6.88%) + D(4.15b)/V(5.49b) * Rd(0.78%) * (1-Tc(0.20)))
Discount Rate = 6.88% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -100.0 | Cagr: -4.19%
[DCF] Terminal Value 86.85% ; FCFF base≈249.9m ; Y1≈263.6m ; Y5≈311.0m
[DCF] Fair Price = 28.07 (EV 9.19b - Net Debt 3.84b = Equity 5.34b / Shares 190.4m; r=6.0% [WACC]; 5y FCF grow 5.96% → 3.0% )
EPS Correlation: 4.41 | EPS CAGR: -1.60% | SUE: 0.45 | # QB: 0
Revenue Correlation: 51.35 | Revenue CAGR: 2.85% | SUE: 0.87 | # QB: 2
EPS next Quarter (2026-06-30): EPS=0.19 | Chg7d=+0.000 | Chg30d=-0.000 | Revisions Net=-20 | Analysts=25
EPS current Year (2026-12-31): EPS=0.58 | Chg7d=+0.000 | Chg30d=-0.000 | Revisions Net=+1 | Growth EPS=-33.6% | Growth Revenue=+1.3%
EPS next Year (2027-12-31): EPS=0.66 | Chg7d=+0.000 | Chg30d=-0.021 | Revisions Net=-17 | Growth EPS=+13.5% | Growth Revenue=+1.0%
[Analyst] Revisions Ratio: -1.00 (0 Up / 20 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -4.1% (Discount Rate 7.9% - Earnings Yield 12.0%)
[Growth] Growth Spread = +4.6% (Analyst 0.5% - Implied -4.1%)